Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

August 14, 2017

Study Completion Date

December 1, 2017

Conditions
VapingNicotine Absorption
Interventions
OTHER

E-cigarette

Subject's own e-cigarette

OTHER

P4M3-1.7%

P4M3 e-liquid concentration of 1.7% nicotine without lactic acid

OTHER

P4M3-1.7%LA

P4M3 e-liquid concentration of 1.7% nicotine with lactic acid

OTHER

P4M3-3%LA

P4M3 e-liquid concentration of 3% nicotine with lactic acid

OTHER

P4M3-4%LA

P4M3 e-liquid concentration of 4% nicotine with lactic acid

Trial Locations (1)

27265

High Point Clinical Trials Center, High Point

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT03379740 - Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants | Biotech Hunter | Biotech Hunter